{"id":"W4379341100","doi":"10.1200/jco.2023.41.16_suppl.e20021","title":"Molecular features and outcomes for patients receiving elranatamab for relapsed or refractory multiple myeloma in MagnetisMM-1.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Institute of Cancer Research; McGill University Health Centre; University of Calgary","funders":"Pfizer","keywords":"Medicine; Internal medicine; Multiple myeloma; Neutropenia; KRAS; Oncology; Adverse effect; Minimal residual disease; Gastroenterology; Bone marrow; Immunology; Cancer; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002487708,0.0001889911,0.0002894198,0.0003873413,0.0003835815,0.0004769615,0.0002145107,0.0004362891,0.002283301],"category_scores_gemma":[0.0006470907,0.0001045452,0.0003704835,0.0004498968,0.0001495002,0.0003473314,0.0002254572,0.0004371266,0.0003789875],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004425721,"about_ca_system_score_gemma":0.0002185836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001156874,"about_ca_topic_score_gemma":0.001307108,"domain_scores_codex":[0.9998811,0.00001796854,0.00001156449,0.00003211479,0.00002241717,0.00003481588],"domain_scores_gemma":[0.9996021,0.00004345704,0.0001705984,0.00001062343,0.0000298873,0.0001432704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003326474,0.0002021291,0.9861494,0.00002742561,0.00006732365,0.0007924094,0.00004489857,0.0002374254,0.001780992,0.00006644115,0.000553116,0.006751986],"study_design_scores_gemma":[0.0001403567,0.001215564,0.9952444,0.000009915234,0.00007487228,0.00188092,0.00006614056,0.0003833165,0.000169822,0.00006936226,0.0007376171,0.000007814067],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979894,0.0003710466,0.0000453645,0.00008889379,0.00000994133,0.00001535466,0.0004377618,0.000005129647,0.001037081],"genre_scores_gemma":[0.998713,0.00007493201,0.00003706217,0.00005405448,0.00001509259,0.00001184336,0.0007659,0.000001684983,0.0003264183],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002283301,"threshold_uncertainty_score":0.007638395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09913919666111909,"score_gpt":0.471155325907031,"score_spread":0.3720161292459119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}